Related Experiment Video
Updated: Jan 20, 2026
Microinjection-Based Delivery of a Therapeutic Agent into an Awake Rodent Brain
Published on: August 29, 2025
Thiophene Derivatives as New Anticancer Agents and Their Therapeutic Delivery Using Folate Receptor-Targeting
Menghui Zhao1, Yaxin Cui1, Lang Zhao1
1School of Life Sciences and College of Chemistry, Jilin University, 2699 Qianjin Street, Changchun 130012, China.
Abstract:
A series of thiophene derivatives were synthesized by functionalization of 2,3-fused thiophene scaffolds. Their cytotoxicity was assessed against HeLa and Hep G2 cells. Compound 480 was identified as a promising candidate because of its low IC50 in HeLa (12.61 μg/mL) and Hep G2 (33.42 μg/mL) cells. The drug was loaded into folic acid (FA)-coated nanoparticles (NPs) to address its poor water solubility and to improve its selectivity for cancer cells. Compound 480 was shown to induce apoptosis by changes in mitochondrial membrane potential (ΔΨm) and the reactive oxygen species level. Furthermore, FA-modified NPs enhanced uptake capacity compared to unmodified controls by flow cytometry. This drug delivered in folate nanocarriers is promising for the treatment of cancers.
More Related Videos
Related Concept Videos
02:24Microinjection-Based Delivery of a Therapeutic Agent into an Awake Rodent Brain
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
10:05Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
05:55Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis